Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 01, 2019

SELL
$97.98 - $114.28 $45.9 Million - $53.5 Million
-468,242 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$81.56 - $100.67 $38.2 Million - $47.1 Million
468,242 New
468,242 $47.1 Million
Q2 2018

Aug 03, 2018

SELL
$79.9 - $89.2 $57.9 Million - $64.6 Million
-724,338 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$71.51 - $84.69 $1.9 Million - $2.24 Million
26,500 Added 3.8%
724,338 $58.8 Million
Q4 2017

Feb 13, 2018

BUY
$63.24 - $72.8 $1.2 Million - $1.38 Million
19,000 Added 2.8%
697,838 $50.3 Million
Q3 2017

Feb 13, 2018

BUY
$59.73 - $65.4 $11.3 Million - $12.4 Million
188,838 Added 38.54%
678,838 $0
Q3 2017

Nov 14, 2017

BUY
$59.73 - $65.4 $5.39 Million - $5.91 Million
90,300 Added 22.59%
490,000 $31.2 Million
Q2 2017

Feb 13, 2018

BUY
N/A
109,700 Added 37.83%
399,700 $24.9 Million
Q2 2017

Nov 14, 2017

BUY
N/A
290,000
290,000 $0

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Close Asset Management LTD Portfolio

Follow Close Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Close Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Close Asset Management LTD with notifications on news.